IMMUNITYBIO INC
IBRX · NASDAQ
Updated at 2026-10-13 14:11:10
- Today's High
- $10.02
- Today’s Low
- $9.56
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $10.59
- Previous Close
- $10.12
- Volume
- 11.05M
- Market Cap
- $10.72B
- P/E Ratio
- --
- EPS
- $-0.96
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, UNITED STATES, 92121
- Country
- US
- Listing Date
- 2015-07-28
- Fiscal Year End
- December
- Shares Outstanding
- 1.04B
- CIK
- 0001326110
- Website
- immunitybio.com
ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy.
Financial Metrics
Revenue
2026-06-30
$51.24M
2026-03-31
$44.2M
2025-12-31
$38.28M
2025-09-30
$32.06M
Operating Expenses
2026-06-30
$112.63M
2026-03-31
$113.75M
2025-12-31
$98.72M
2025-09-30
$83.56M
Net Income
2026-06-30
-$230.37M
2026-03-31
-$632.78M
2025-12-31
-$61.94M
2025-09-30
-$67.25M
Net Profit Margin
2026-06-30
-449.6%
2026-03-31
-1.43K%
2025-12-31
-161.79%
2025-09-30
-209.76%
Earnings Per Share
2026-06-30
$-0.08
2026-03-31
$-0.08
2025-12-31
$-0.06
2025-09-30
$-0.07
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$225.96M
2026-03-31
-$599.94M
2025-12-31
-$31.03M
2025-09-30
-$35.77M
Effective Tax Rate
2026-06-30
--
2026-03-31
0%
2025-12-31
0.21%
2025-09-30
0.05%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $51.24M | $44.2M | $38.28M | $32.06M |
| Operating Expenses | $112.63M | $113.75M | $98.72M | $83.56M |
| Net Income | -$230.37M | -$632.78M | -$61.94M | -$67.25M |
| Net Profit Margin | -449.6% | -1.43K% | -161.79% | -209.76% |
| Earnings Per Share | $-0.08 | $-0.08 | $-0.06 | $-0.07 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$225.96M | -$599.94M | -$31.03M | -$35.77M |
| Effective Tax Rate | -- | 0% | 0.21% | 0.05% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.